Vaccines 2026

About Vaccines 2026 | Hybrid Event

We are delighted to announce the 3rd Edition of the International Vaccine Congress (Vaccines 2026), scheduled to take place from September 14–16, 2026, in Rome, Italy, and virtually. This prestigious hybrid event brings together global leaders in vaccine research, development, and policy to explore the latest scientific advances and collaborative strategies in the field of immunization.

Under the theme “Innovating for Immunity: Vaccines in the Era of Global Challenges” the congress aims to highlight groundbreaking discoveries, emerging technologies, and forward-thinking approaches that are transforming the landscape of vaccine research and public health worldwide.

Vaccines 2026 invites scientists, immunologists, microbiologists, epidemiologists, clinical researchers, public health officials, pharmaceutical experts, and policymakers to join an interactive platform designed to foster meaningful dialogue, collaboration, and innovation.

The scientific sessions will span a wide spectrum of topics — from vaccine discovery, delivery systems, and clinical trials to pandemic preparedness, global immunization policies, and the integration of digital health tools. Attendees can expect high-level presentations, keynote addresses, panel discussions, and networking opportunities that connect academia, industry, and government stakeholders.

Set against the inspiring backdrop of Rome, Italy — the Eternal City, Vaccines 2026 offers a unique opportunity to engage with global experts while experiencing one of the world’s most historic and beautiful destinations. Participants may also join virtually, ensuring access and inclusivity for attendees across all regions.

Join us in advancing the science of immunization and shaping the future of global health at the 3rd International Vaccine Congress – Vaccines 2026, in Rome, Italy, and Online.